Resonance Health (formerly GEO2 Ltd)
05-Apr-04
Announce subsidiary Inner Vision Biometrics Pty Ltd and the international pharmaceutical group Novartis have concluded an agreement which will expand the provision of FerriScan testing services to Novartis to include an additional three overseas clinical trials relating to iron overload diseases.
